A detailed history of Ameritas Investment Partners, Inc. transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 6,130 shares of VRDN stock, worth $118,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,130
Previous 6,130 -0.0%
Holding current value
$118,370
Previous $79,000 75.95%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$11.6 - $17.26 $13,560 - $20,176
1,169 Added 23.56%
6,130 $79,000
Q1 2024

May 13, 2024

BUY
$17.09 - $23.82 $13,654 - $19,032
799 Added 19.2%
4,961 $86,000
Q3 2023

Nov 13, 2023

BUY
$15.16 - $24.7 $10,263 - $16,721
677 Added 19.43%
4,162 $63,000
Q2 2023

Aug 11, 2023

BUY
$22.57 - $29.67 $10,359 - $13,618
459 Added 15.17%
3,485 $82,000
Q4 2022

Feb 13, 2023

BUY
$18.78 - $29.74 $20,488 - $32,446
1,091 Added 56.38%
3,026 $88,000
Q2 2022

Aug 12, 2022

BUY
$9.55 - $19.0 $18,479 - $36,765
1,935 New
1,935 $22,000

Others Institutions Holding VRDN

About Viridian Therapeutics, Inc.\DE


  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $770M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.